Page 2 - Microba Life Sciences News Today

Issuer: Mainz BioMed N.V. / Key word: Half Year Results Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update 15.08.2023 /... -Today at 03:03 am- MarketScreener

ColoAlert® Revenue Increases 108% Year Over Year in the First Six Months of 2023 ColoFuture and eAArly Detect Studies on Track to Report Results in September and in Q4, 2023 BERKELEY, Calif. and MAINZ, Germany,

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

MaaT Pharma, a clinical-stage biotech company focused on the development of Microbiome Ecosystem Therapies (MET) dedicated to improving survival outcomes for patients with cancer, is now a member of Microbiome Therapeutics Innovation Group (MTIG).

/PRNewswire/ -- The Microbiome Therapeutics Innovation Group (MTIG) today announced the addition of MaaT Pharma to its coalition of companies leading the...

Microba and Sonic Healthcare have now signed a commercial agreement to deliver Microba’s advanced infectious disease testing technology MetaPanel™ into Australia This new metagenomic diagnostic test has been designed to identify a comprehensive panel of pathogenic microorganisms and genes to advance the standard of care in gastrointestinal infectious disease pathology This is the first executed agreement between Microba and Sonic Healthcare (ASX: SHL) since Sonic Healthcare acquired ...

Mainz Biomed (NASDAQ:MYNZ – Free Report) and ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation. Analyst Recommendations This is a breakdown of recent ratings […]

BRISBANE, Australia--(BUSINESS WIRE)--Jun 27, 2023--

Probiota Americas is just over two weeks away. With key scientific insights into the category’s most disruptive technology – A.I., CRISPR, and -omics – and a look at the microbiomes of centenarians, don’t wait to register!

The rise of dietary supplements to help manage stress was one of the big success stories from the pandemic years. While much of this success was linked to products containing adaptogenic herbs (we’re looking at you, Ashwagandha), the past couple of years has seen a surge in probiotics with stress management/ anti-anxiety positioning.